Geode Capital Management
DMRA

Geode Capital Management’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Geode Capital Management’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.25M Buy
241,126
+229,553
+1,984% +$5.9M ﹤0.01% 2633
2025
Q4 		$266K Buy
+11,573
New +$201K ﹤0.01% 3817
2024
Q3 		– Sell
-8,565
Closed -$102K – 4554
2024
Q2 		$102K Buy
8,565
+232
+3% +$3.66K ﹤0.01% 4137
2024
Q1 		$163K Hold
8,333
– – ﹤0.01% 4004
2023
Q4 		$150K Hold
8,333
– – ﹤0.01% 4043
2023
Q3 		$150K Buy
8,333
+585
+8% +$23K ﹤0.01% 4095
2023
Q2 		$488K Buy
7,748
+3,390
+78% +$185K ﹤0.01% 3651
2023
Q1 		$217K Hold
4,358
– – ﹤0.01% 4007
2022
Q4 		$125K Buy
4,358
+113
+3% +$4.69K ﹤0.01% 4308
2022
Q3 		$200K Hold
4,245
– – ﹤0.01% 4213
2022
Q2 		$183K Buy
4,245
+358
+9% +$16.4K ﹤0.01% 4322
2022
Q1 		$213K Buy
3,887
+42
+1% +$2.36K ﹤0.01% 4348
2021
Q4 		$291K Buy
3,845
+912
+31% +$71.6K ﹤0.01% 4304
2021
Q3 		$263K Sell
2,933
-56
-2% -$5.99K ﹤0.01% 4326
2021
Q2 		$378K Buy
+2,989
New +$407K ﹤0.01% 4070

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Geode Capital Management's DMRA Position: Q1 2026 in Review

Geode Capital Management increased its Damora Therapeutics, Inc. Ordinary Shares (DMRA) stake by 1,984% in Q1 2026, buying an estimated $5.9M and bringing the position to 241,126 shares worth $6.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

Geode Capital Management first reported a position in DMRA in Q2 2021 and has held it in 15 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Geode Capital Management held 241,126 shares of Damora Therapeutics, Inc. Ordinary Shares worth $6.25M as of Q1 2026.
  • Geode Capital Management bought 229,553 Damora Therapeutics, Inc. Ordinary Shares shares in Q1 2026, an estimated $5.9M.
  • Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2633 holding.
  • Geode Capital Management first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q2 2021 and has held it in 15 quarters since.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.